Protein Extracts from Single Cell Protein & Other Conventional Sources Market Size, Share, Growth and Forecast (2026 - 2036)

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Analysis and Forecast by Fact.MR

The protein extracts from single cell protein & other conventional sources market, valued at USD 23.5 billion in 2025, is expanding at a 6.5% CAGR to reach USD 46.98 billion by 2036. This market encompasses protein ingredients derived from microbial fermentation (bacteria, yeast, algae, fungi) and conventional extraction from plant and animal sources, serving animal nutrition, human food, pharmaceutical, and industrial biotechnology applications. Growth is shaped by the global protein supply gap, rising demand for sustainable protein alternatives, antibiotic-free animal feed formulations, and expanding applications for fermentation-derived protein in food and pharmaceutical manufacturing.

Summary of Protein Extracts from Single Cell Protein & Other Conventional Sources Market

• Market Snapshot
  • The market is valued at USD 23.5 billion in 2025.
  • Estimated market value for 2026 is USD 25.027 billion, projected to reach USD 46.98 billion by 2036.
  • A CAGR of 6.5% is forecast for the 2026 to 2036 assessment period.
  • Incremental opportunity of USD 21.953 billion between 2026 and 2036.
  • Conventional protein extracts hold 42.6% of the product segment, with fermentation technology at 44.7% of technology demand.
  • India and South Africa are the fastest-growing markets for protein extract adoption.
• Demand and Growth Drivers
  • Global protein demand is projected to increase 50% by 2050 per FAO estimates, driven by population growth and rising per-capita protein consumption in developing economies. Conventional agriculture and fisheries alone cannot meet this demand, creating structural need for alternative protein production systems.
  • Antibiotic reduction mandates in animal agriculture are driving demand for single cell protein (SCP) as a high-quality feed ingredient that reduces dependency on antibiotic growth promoters while delivering comparable or superior animal performance metrics.
  • Precision fermentation technology is enabling production of specific functional proteins (enzymes, bioactive peptides, structural proteins) that cannot be efficiently extracted from conventional agricultural sources, opening new pharmaceutical and food ingredient applications.
  • Sustainability considerations are accelerating SCP adoption, as microbial protein production requires 10 to 100 times less land and 5 to 25 times less water than conventional animal protein production per unit of protein output.
• Product and Segment View
  • Conventional protein extracts hold 42.6% of the product segment, reflecting the established position of plant and animal-derived protein extraction in feed and food manufacturing.
  • Animal nutrition captures 38.9% of application demand, driven by aquaculture and livestock feed formulation requirements for high-quality protein ingredients.
  • Fermentation technology accounts for 44.7% of technology demand, reflecting the central role of microbial fermentation in SCP production.
  • Key segmentation includes:
    • Product: Conventional Protein Extracts, Single Cell Protein Based Protein Extracts, Fungal Protein Extracts, Hybrid Protein Blends
    • Source: Conventional Source, Microbial Source
    • Application: Animal Nutrition, Human Nutrition, Industrial Application
    • End Use: Food and Beverage Industry, Animal Feed Industry, Healthcare and Pharmaceuticals, Industrial Biotechnology
    • Technology: Fermentation Technology, Downstream Processing, Bioreactor Systems
    • Distribution Channel: Direct Sales, Distributors and Traders, Online B2B Platforms
• Geography and Competitive Outlook
  • North America accounts for significant revenue, with the USA generating USD 9.32 billion in 2025.
  • East Asia is expanding, with Japan contributing USD 1.334 billion and South Korea contributing USD 0.741 billion in 2025.
  • Unilever holds approximately 12.0% of global market share through its protein ingredient sourcing and food manufacturing operations.
  • Taiwan Chlorella Manufacturing Company, Corbion Biotech, and Euglena Co. compete in the microbial protein production segment.
• Analyst Opinion
  • The protein extracts market is at a technological inflection point where microbial fermentation is transitioning from niche supplement production to industrial-scale protein manufacturing. Conventional protein extraction from plant and animal sources remains dominant by volume, but single cell protein production is closing the cost gap as fermentation scale increases and downstream processing efficiency improves. Companies that can achieve production costs below USD 2 per kilogram of protein for SCP will reach price parity with fishmeal and soy protein concentrate, unlocking mass-market animal feed applications.

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• Aquaculture feed demand for high-quality protein ingredients is growing at 6 to 8% annually as global farmed fish production expands. Fishmeal, the traditional aquaculture protein source, faces supply constraints (global fishmeal production is capped at approximately 5 million tonnes annually), driving adoption of SCP as a partial fishmeal replacement. Commercial feeding trials demonstrate that SCP can replace 25 to 50% of fishmeal in salmon and shrimp diets without compromising growth performance.
• Precision fermentation companies (Calysta, Unibio, KnipBio) are scaling gas fermentation and methanol oxidation technologies that convert natural gas, methanol, or CO2 into microbial protein. These production systems are feedstock-flexible, geographically unrestricted, and capable of year-round continuous operation, addressing the seasonality and climate vulnerability of agricultural protein production.
• Mycoprotein production for human food applications is scaling beyond Quorn Foods. Fungal fermentation produces protein-rich biomass with meat-like fibre structure, and new entrants (Nature's Fynd, Meati Foods, ENOUGH) are expanding production capacity using different fungal species and fermentation substrates.

Key Market Constraints

• Production cost for SCP remains 2 to 4 times higher than conventional protein sources on a per-kilogram basis. Fermentation energy costs, downstream processing (cell disruption, purification, drying), and fermentation media expenses create a cost structure that limits SCP to premium applications where functional benefits justify the price premium.
• Regulatory approval timelines for novel protein ingredients in food and feed applications create market entry delays. EU Novel Food Regulation, FDA GRAS (Generally Recognized as Safe) determination, and national feed additive approval processes require 12 to 36 months of safety evaluation, delaying commercialisation of new SCP products.
• Consumer acceptance of fermentation-derived protein in human food applications remains uncertain. While mycoprotein (Quorn) has achieved mainstream acceptance in the UK and Europe, consumer awareness and acceptance of bacterial and algal protein in food products varies significantly across markets.

Key Opportunity Areas

• Gas fermentation SCP production using industrial CO2 and methane as feedstocks creates a circular economy proposition that attracts carbon credit revenue alongside protein sales. Companies such as Calysta and Deep Branch are positioning SCP production as a carbon utilisation technology, accessing climate finance alongside food and feed market revenue.
• Pharmaceutical excipient applications for highly purified microbial protein fractions are an emerging high-value niche. Cell-free protein extracts, recombinant protein production platforms, and fermentation-derived bioactive peptides serve pharmaceutical manufacturing requirements where purity specifications command prices 10 to 100 times above food-grade protein.
• Pet food premiumisation is creating demand for novel protein ingredients, with SCP positioned as a hypoallergenic, sustainable protein source for premium pet nutrition. Pet food manufacturers are incorporating SCP into novel protein diets targeting dogs and cats with food sensitivities.

Segment-wise Analysis of the Protein Extracts from Single Cell Protein & Other Conventional Sources Market

• Conventional protein extracts hold 42.6% of the product segment, reflecting the established position of plant and animal-derived protein extraction.
• Animal nutrition captures 38.9% of application demand, driven by aquaculture and livestock feed requirements.
• Fermentation technology accounts for 44.7% of technology demand, reflecting the central role of microbial fermentation in SCP production.

Which product type dominates the Protein Extracts Market?

Conventional protein extracts control 42.6% of the product segment. Soy protein concentrate, wheat gluten, pea protein, and animal-derived protein meals remain the volume leaders in both feed and food applications, benefiting from established production infrastructure, regulatory approval, and price competitiveness. Conventional protein extraction processes (solvent extraction, enzymatic hydrolysis, mechanical separation) are mature technologies with optimised cost structures.

Single cell protein-based extracts hold the second-largest position and are the fastest-growing product type. Fungal protein extracts and hybrid protein blends serve specific application niches where functional properties or sustainability credentials justify price premiums over conventional alternatives.

Which application drives demand in the Protein Extracts Market?

Animal nutrition accounts for 38.9% of application demand. Aquaculture feed is the largest single application within animal nutrition, where high-quality protein ingredients directly influence fish growth rates, feed conversion ratios, and flesh quality. Livestock feed (poultry, swine) is the second major animal nutrition application, where SCP serves as a replacement for antibiotic growth promoters and a supplement to soy-based feed formulations.

Human nutrition holds the second-largest application share, driven by plant-based protein ingredient demand for meat alternatives, sports nutrition, and functional food formulations. Industrial applications serve pharmaceutical excipient, enzyme production, and biotechnology manufacturing requirements.

Which technology leads the Protein Extracts Market?

Fermentation technology accounts for 44.7% of technology demand. Submerged fermentation (liquid culture) and solid-state fermentation are the primary production methods for SCP, with submerged fermentation dominating commercial-scale operations. Fermentation technology selection depends on the target organism (bacteria, yeast, fungi, algae), the feedstock (sugars, methanol, natural gas, CO2), and the target protein functionality.

Downstream processing holds the second-largest technology share, encompassing cell disruption, protein extraction, purification, and drying operations that convert raw fermentation biomass into finished protein ingredients.

Which Product Trend is Shaping the Next Phase of Growth in the Protein Extracts from Single Cell Protein & Other Conventional Sources Market?

The fastest-growing product trend in the protein extracts market is the application of precision fermentation to produce specific functional proteins that cannot be efficiently obtained from conventional sources. Traditional SCP production focuses on bulk biomass protein, where the entire microbial cell is harvested as a protein ingredient. Precision fermentation programmes the microbial host to produce a specific target protein (casein, whey, collagen, egg albumin) that is secreted into the fermentation medium and purified.

The commercial significance is transformative. Precision fermentation enables production of animal-identical proteins without animal agriculture, addressing both sustainability and food security concerns. Companies including Perfect Day (dairy proteins), Clara Foods (egg proteins), and Geltor (collagen) are scaling production. The technology is expanding beyond food into pharmaceutical protein production, where fermentation-derived proteins serve as drug delivery vehicles, diagnostic reagents, and vaccine components. Precision fermentation protein commands prices of USD 10 to USD 50 per kilogram in food applications, creating a high-margin segment within the broader protein extracts market.

Regional Outlook Across Key Markets

• North America is a major market, with the USA contributing USD 9.32 billion in 2025 revenue.
• East Asia is expanding, with Japan at USD 1.334 billion and South Korea at USD 0.741 billion in 2025.
• South Asia and Pacific is growing rapidly, with India leading through fermentation industry expansion.
• Middle East and Africa is emerging, with South Africa leading through industrial biotechnology development.

CAGR Table

Source: Fact.MR analysis, based on proprietary forecasting model and primary research.

India: fermentation industry expansion and protein demand gap drive leadership

India leads global growth. India's fermentation industry, the world's third largest by capacity, provides production infrastructure for SCP manufacturing. India faces a significant protein deficit, with per-capita protein consumption below WHO recommendations in many states. Government programmes including the National Mission on Oilseeds and Oil Palm are expanding domestic protein production capacity.

• India's industrial biotechnology sector attracted over USD 1.2 billion in investment in 2024, per DBT (Department of Biotechnology) data, with protein fermentation among the fastest-growing sub-sectors.

South Africa: industrial biotechnology development and protein security drive adoption

South Africa records strong growth driven by government investment in industrial biotechnology and protein security programmes. South Africa's Council for Scientific and Industrial Research (CSIR) is developing SCP production technologies using local agricultural waste feedstocks, targeting both animal feed and human food protein applications.

• South Africa's biotechnology sector grew 15% in 2024, per Department of Science and Innovation data, with protein production technology attracting public-private partnership funding.

China: state-led fermentation capacity expansion and feed industry demand accelerate growth

China's growth is driven by strategic government investment in fermentation capacity for protein production. China's 14th Five-Year Plan identifies biological manufacturing as a priority sector, with SCP production targeted for animal feed applications to reduce soybean import dependency. Chinese fermentation capacity exceeds 30 million cubic metres, providing infrastructure for SCP scale-up.

• China's biological manufacturing sector received over CNY 50 billion in government funding between 2021 and 2024, per Ministry of Science and Technology data.

Brazil: agricultural feedstock availability and aquaculture feed demand drive growth

Brazil's growth reflects its abundant agricultural feedstock supply (sugarcane, corn, soy processing residues) suitable for fermentation-based SCP production. Brazilian aquaculture, the fourth-largest globally, creates sustained demand for protein feed ingredients, and domestic SCP production reduces import dependency for premium protein sources.

• Brazil's aquaculture feed market consumed over 1.5 million tonnes of protein ingredients in 2024, per SINDIRAQ data, with alternative protein sources gaining formulation share.

USA: precision fermentation investment and regulatory leadership define the market

The USA generates USD 9.32 billion in 2025 revenue. Growth is driven by venture capital investment in precision fermentation companies and FDA regulatory pathways for novel protein ingredients. US-based companies including Perfect Day, Clara Foods, and Calysta are leading global SCP commercialisation, supported by a regulatory environment that has established GRAS determination processes for fermentation-derived proteins.

• US precision fermentation companies raised over USD 2 billion in venture funding between 2022 and 2024, per PitchBook data, with protein production as the largest application category.

Japan: biotechnology expertise and premium food ingredient demand support growth

Japan contributes USD 1.334 billion in 2025. Japanese SCP development benefits from the country's advanced fermentation industry (Ajinomoto, Kyowa Hakko) and consumer acceptance of fermentation-derived food ingredients. Euglena Co. is scaling algal protein production for food and cosmetic applications using proprietary cultivation technology.

• Japan's functional food ingredients market exceeded USD 20 billion in 2024, per MHLW (Ministry of Health, Labour and Welfare) data, with fermentation-derived protein ingredients gaining formulation share.

Germany: industrial biotechnology strength and feed industry demand drive positioning

Germany's growth reflects its position as Europe's largest industrial biotechnology market. German research institutions (Fraunhofer, Max Planck) and industrial companies are developing SCP production technologies for animal feed and food ingredient applications. Germany's large compound feed industry creates domestic demand for protein ingredients.

• Germany's industrial biotechnology sector generated over EUR 3 billion in revenue in 2024, per BIO Deutschland data, with protein fermentation as a growth segment.

Competitive Benchmarking and Company Positioning

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Analysis By Company

• Unilever holds approximately 12.0% of global revenue through its protein ingredient sourcing operations and food manufacturing that incorporates both conventional and fermentation-derived protein ingredients.
• Taiwan Chlorella Manufacturing Company and Earthrise Nutritional compete in the algal protein segment, producing spirulina and chlorella-based protein products for supplement and food applications.
• Corbion Biotech, KnipBio, and BlueBio Tech serve the SCP production segment through proprietary fermentation platforms targeting aquaculture feed and human nutrition applications.

The competitive structure is moderately fragmented, with Unilever holding the largest share at 12.0%. Unilever's position reflects its role as a major protein ingredient buyer and food manufacturer rather than a primary protein producer. The company's procurement scale and reformulation programmes that incorporate SCP and conventional protein extracts give it purchasing influence across the protein ingredient supply chain.

Competition in the SCP segment is technology-driven, with companies differentiated by fermentation organism, feedstock flexibility, and downstream processing capability. The competitive dynamic favours companies that can achieve production-cost parity with conventional protein sources, as cost remains the primary barrier to SCP adoption in price-sensitive animal feed applications.

Key Companies in the Protein Extracts from Single Cell Protein & Other Conventional Sources Market

The protein extracts competitive field includes Unilever, Taiwan Chlorella Manufacturing Company, CBH, Xiamen Hyfine Gelatin Co. Ltd., BlueBio Tech GmbH, Euglena Co. Ltd., Corbion Biotech Inc., KnipBio, Hangzhou, and Earthrise Nutritional.

Recent Industry Developments

• Corbion Biotech: algal protein production scale-up (2025)
  • Corbion Biotech expanded its algal protein production capacity at its Brazilian facility, increasing annual output of algal protein ingredients for aquaculture feed and human nutrition applications.
• Euglena Co.: food-grade euglena protein launch (2025)
  • Euglena Co. launched a food-grade euglena protein ingredient for the Japanese functional food market, with MHLW-approved health claims related to protein content and digestibility.
• KnipBio: methanol-based SCP commercial production (2026)
  • KnipBio commenced commercial-scale production of its methylotrophic yeast-based SCP product for aquaculture feed applications, using methanol as a carbon source for continuous fermentation.
• Taiwan Chlorella: expanded spirulina protein capacity (2025)
  • Taiwan Chlorella Manufacturing Company expanded its spirulina cultivation and protein extraction capacity, targeting growing demand for algal protein ingredients in the global supplement and food ingredient markets.

Leading Companies Shaping the Protein Extracts from Single Cell Protein & Other Conventional Sources Market

• Global Players

  • Unilever
  • Corbion Biotech, Inc.
  • Euglena Co. Ltd.
  • Taiwan Chlorella Manufacturing Company
  • Earthrise Nutritional

• Regional Players

  • CBH
  • Xiamen Hyfine Gelatin Co. Ltd.
  • BlueBio Tech GmbH
  • Hangzhou

• Emerging / Start-up Players

  • KnipBio
  • Calysta Inc.
  • Deep Branch Biotechnology

Sources and Research References

• Company annual reports from Unilever, Euglena Co., and Corbion Biotech.
• FAO global protein consumption and production statistics.
• DBT (Department of Biotechnology, India) industrial biotechnology investment data.
• FDA GRAS determination database for novel protein ingredients.
• PitchBook venture capital investment data for precision fermentation companies.
• BIO Deutschland industrial biotechnology sector reports.

All cited sources are first-party company filings, government agencies, regulatory databases, or industry associations. No syndicated market research reports were used.

Key Questions This Report Addresses

• What is the projected market value for protein extracts by 2036?
• Which product type holds the largest share?
• What CAGR is forecast from 2026 to 2036?
• How is precision fermentation changing protein production?
• Which countries are growing fastest?
• What is the competitive structure?
• How does SCP cost compare to conventional protein?
• What role does aquaculture feed play in SCP demand?
• How are regulatory frameworks affecting SCP commercialisation?

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Definition

The protein extracts from single cell protein & other conventional sources market encompasses the production and sale of protein ingredients derived from microbial fermentation (bacteria, yeast, algae, fungi) and conventional extraction from plant, animal, and marine sources. Products serve as protein ingredients in animal feed, human food, pharmaceutical, and industrial applications.

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Inclusions

• Single cell protein products derived from bacterial, yeast, algal, and fungal fermentation.
• Conventional protein extracts from soy, wheat, pea, rice, and animal sources.
• Fungal protein products including mycoprotein and filamentous fungal biomass.
• Hybrid protein blends combining microbial and conventional protein sources.

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Exclusions

• Whole food plant-based protein products (tofu, tempeh) sold as consumer food items.
• Pharmaceutical-grade recombinant proteins produced for therapeutic drug applications.
• Enzyme products manufactured through fermentation but sold as processing aids rather than protein ingredients.
• Insect protein products classified separately from single cell protein.

Protein Extracts from Single Cell Protein & Other Conventional Sources Market Research Methodology

• Primary research with protein ingredient manufacturers, fermentation companies, animal feed formulators, and food processing companies across 12 countries.
• Revenue modelling based on protein production volumes, fermentation capacity data, and manufacturer-reported sales.
• Pricing analysis using B2B protein ingredient price lists, feed commodity exchange data, and procurement contract records.
• Competitive share estimation through company annual reports, biotechnology patent databases, and fermentation capacity registries.
• Demand validation through FAO protein consumption statistics, animal feed production data, and food ingredient trade flow analysis.